What is DBVTF's health score?

DBV Technologies S.A. (DBVTF) has a TradeApes health score of 39 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DBVTF's estimated fair value?

Based on our 5-year discounted cash flow model, DBV Technologies S.A.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is DBVTF undervalued or overvalued?

Our model currently rates DBVTF as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DBVTF... Refresh in a moment for the full analysis.

DBV Technologies S.A. (DBVTF)

Healthcare Fair Value High weak

Updated: 2026-04-21

TradeApes Score

reduce

Financial Strength

40 Weak

Operating Trend

55 Mixed

Relative Value

40 Weak

Capital Allocation

10 Stressed

Risk

35 Weak

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.